MOVYMIA

Subcutaneous biosimilar medications for patient self-administration

COMMERCIAL BRAND
MOVYMIA

ACTIVE PRINCIPLE
TERIPARATIDE

TYPE OF DEVICE
INJECTABLE SOLUTION WITH PEN

LATEX
DO NOT

TEMPERING TIME
DO NOT

START OF INJECTION
Button

CLICK TO THE START (IN PEN)
DO NOT

CLICK AT THE END (IN PEN)
DO NOT

BioSim Newsletter

Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.

SUBSCRIBE